Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
11.71
0.13 (1.12%)
At close: Sep 16, 2025, 10:44 AM
1.12%
Bid 11.67
Market Cap 1.25B
Revenue (ttm) 262M
Net Income (ttm) -306M
EPS (ttm) -3.14
PE Ratio (ttm) -3.73
Forward PE -2.75
Analyst Buy
Dividends n/a
Ask 11.72
Volume 49,365
Avg. Volume (20D) 867,073.7
Open 11.58
Previous Close 11.58
Day's Range 11.58 - 11.78
52-Week Range 6.50 - 18.98
Beta 0.82
Ex-Dividend Date n/a

About RCUS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCUS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RCUS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Arcus Biosciences Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-1.35%
Arcus Biosciences shares are trading lower after t... Unlock content with Pro Subscription
6 months ago
-16.34%
Arcus Biosciences shares are trading lower after the company announced a $150 million stock offering.